Responding to SARS-CoV-2 in South Africa: what can we learn from drug-resistant tuberculosis?
Eur Respir J
; 56(1)2020 07.
Article
in English
| MEDLINE | ID: covidwho-429761
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Tuberculosis, Multidrug-Resistant
/
Coronavirus Infections
/
Interdisciplinary Communication
/
Pandemics
Type of study:
Diagnostic study
/
Randomized controlled trials
Limits:
Humans
Country/Region as subject:
Africa
Language:
English
Year:
2020
Document Type:
Article
Affiliation country:
13993003.01369-2020
Similar
MEDLINE
...
LILACS
LIS